ADBiotech Co., Ltd. (KOSDAQ:179530)
2,650.00
-25.00 (-0.93%)
At close: Apr 28, 2026
ADBiotech Market Cap
ADBiotech has a market cap or net worth of 52.15 billion as of April 29, 2026. Its market cap has increased by 205.86% in one year.
Market Cap
52.15B
Enterprise Value
57.54B
Revenue
12.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,650.00
Market Cap Chart
Since December 24, 2019, ADBiotech's market cap has increased from 25.35B to 52.15B, an increase of 105.76%. That is a compound annual growth rate of 12.04%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J2KBIO | 48.59B |
| Parataxis Korea | 44.13B |
| EyeGene | 62.90B |
| Poongjeon Pharmacy CO.,LTD. | 40.98B |
| HLB Pep | 67.47B |
| Aptamer Sciences | 68.64B |
| Ark Solutions | 68.91B |
| Psomagen | 70.02B |